Composition
- Active ingredients
- DURVALUMAB 50MG/ML
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application BLA761069.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Imfinzi
- Active substance
- durvalumab
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Astrazeneca UK LTD
- Status
- Prescription
- FDA approval
- 1 May 2017
- Application
- BLA761069-001